<VariationArchive RecordType="classified" VariationID="458669" VariationName="NC_000009.12:g.(?_130458401)_(130458589_?)del" VariationType="Deletion" Accession="VCV000458669" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2017-12-26" MostRecentSubmission="2017-12-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="458127" VariationID="458669">
      <GeneList>
        <Gene Symbol="ASS1" FullName="argininosuccinate synthase 1" GeneID="445" HGNC_ID="HGNC:758" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="130444707" stop="130501274" display_start="130444707" display_stop="130501274" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="133320093" stop="133376660" display_start="133320093" display_stop="133376660" Strand="+" />
          </Location>
          <OMIM>603470</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000009.12:g.(?_130458401)_(130458589_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" innerStart="130458401" innerStop="130458589" display_start="130458401" display_stop="130458589" variantLength="189" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.(?_130458401)_(130458589_?)del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.(?_130458401)_(130458589_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000009.12:g.(?_130458401)_(130458589_?)del AND Citrullinemia type I" Accession="RCV000557231" Version="1">
        <ClassifiedConditionList TraitSetID="1757">
          <ClassifiedCondition DB="MedGen" ID="C4721769">Citrullinemia type I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-12-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-12-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-12-26" MostRecentSubmission="2017-12-26">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1757" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1459" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Citrullinemia type I</ElementValue>
                <XRef ID="Citrullinemia+Type+I/1651" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008988" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Classic citrullinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ASS deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Citrullinemia 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">argininosuccinate synthetase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CTNL1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CTLN1</ElementValue>
                <XRef Type="MIM" ID="215700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Citrullinemia type I (CTLN1) presents as a clinical spectrum that includes an acute neonatal form (the "classic" form), a milder late-onset form (the "non-classic" form), a form without symptoms or hyperammonemia, and a form in which women have onset of severe symptoms during pregnancy or post partum. Distinction between the clinical forms is based on clinical findings and is not clear-cut. Infants with the acute neonatal form appear normal at birth. Shortly thereafter, they develop hyperammonemia and become progressively lethargic, feed poorly, often vomit, and may develop signs of increased intracranial pressure (ICP). Without prompt intervention, hyperammonemia and the accumulation of other toxic metabolites (e.g., glutamine) result in increased ICP, increased neuromuscular tone, spasticity, ankle clonus, seizures, loss of consciousness, and death. Children with the severe form who are treated promptly may survive for an indeterminate period of time, but usually with significant neurologic deficits. The late-onset form may be milder than that seen in the acute neonatal form, for unknown reasons. The episodes of hyperammonemia are similar to those seen in the acute neonatal form, but the initial neurologic findings may be more subtle because of the older age of the affected individuals.</Attribute>
                <XRef ID="NBK1458" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301631</ID>
                <ID Source="BookShelf">NBK1458</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301396</ID>
                <ID Source="BookShelf">NBK1217</ID>
              </Citation>
              <XRef ID="247525" DB="Orphanet" />
              <XRef ID="C4721769" DB="MedGen" />
              <XRef ID="MONDO:0008988" DB="MONDO" />
              <XRef Type="MIM" ID="215700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1222264" SubmissionDate="2017-10-05" DateLastUpdated="2017-12-26" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1290951|MedGen:C0175683" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000630046" DateUpdated="2017-12-26" DateCreated="2017-12-26" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-12-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment Type="public">This variant is a gross deletion of the genomic region encompassing exon 5 of the ASS1 gene. This leads to an in-frame deletion, preserving the integrity of the reading frame. Exon 5 deletions of ASS1 have been observed in individuals affected with citrullinemia type I (PMID: 2615645, Invitae). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.(?_133333788)_(133333976_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0175683" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3109251</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1222264" TraitType="Disease" MappingType="XRef" MappingValue="C0175683" MappingRef="MedGen">
        <MedGen CUI="C0175683" Name="Citrullinemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

